The present invention is directed to novel nanomolar and picomolar inhibitors of HIV reverse transcriptase, pharmaceutical compositions therefrom and methods for inhibiting reverse transcriptase and treating HIV infections, especially included drug resistant strains of HIV-1 and HIV-2 and/or secondary disease states and/or conditions which occur as a consequence of HIV infection.
Synthesis of functionalized 3-chloro-1-naphthols via Friedel–Crafts acylation of vinyl chlorides
作者:Xin Linghu、Mark McLaughlin、Cheng-yi Chen、Robert A. Reamer、Lisa Dimichele、Ian W. Davies
DOI:10.1016/j.tetlet.2012.01.011
日期:2012.3
Friedel-Crafts type cyclization of vinyl chlorides was developed into a general method for the synthesis of functionalized naphthols. The chloro functional group contained within these products allowed for further elaboration via cross-coupling reactions, leading to increased structural complexity. (C) 2012 Elsevier Ltd. All rights reserved.
US9382245B2
申请人:——
公开号:US9382245B2
公开(公告)日:2016-07-05
Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers
作者:Won-Gil Lee、Kathleen M. Frey、Ricardo Gallardo-Macias、Krasimir A. Spasov、Mariela Bollini、Karen S. Anderson、William L. Jorgensen
DOI:10.1021/ml5003713
日期:2014.11.13
Catechol diethers that incorporate a 6-cyano-1-naphthyl substituent have been explored as non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs). Promising compounds are reported that show midpicomolar activity against the wild-type virus and sub-20 nM activity against viral variants bearing Tyr181Cys and Lys103Asn mutations in HIV-RT. An X-ray crystal structure at 2.49 angstrom resolution is also reported for the key compound 6e with HIV-RT.